vs

Side-by-side financial comparison of Northwest Natural Holding Co (NWN) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.

Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $394.2M, roughly 1.6× Northwest Natural Holding Co). On growth, Northwest Natural Holding Co posted the faster year-over-year revenue change (6.3% vs 4.8%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs -4.6%).

NW Natural, formerly Northwest Natural Gas Company, is an American publicly traded utility headquartered in Portland, Oregon, United States. Primarily a natural gas distributor, the company services residential, commercial, and industrial customers in Western Oregon and Southwest Washington in the Pacific Northwest. NW Natural also owns water utilities. Founded in 1859, the company has approximately 800,000 customers and revenues of over $1 billion annually.

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

NWN vs RPRX — Head-to-Head

Bigger by revenue
RPRX
RPRX
1.6× larger
RPRX
$622.0M
$394.2M
NWN
Growing faster (revenue YoY)
NWN
NWN
+1.5% gap
NWN
6.3%
4.8%
RPRX
Faster 2-yr revenue CAGR
RPRX
RPRX
Annualised
RPRX
4.6%
-4.6%
NWN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NWN
NWN
RPRX
RPRX
Revenue
$394.2M
$622.0M
Net Profit
$214.2M
Gross Margin
Operating Margin
28.4%
62.4%
Net Margin
34.4%
Revenue YoY
6.3%
4.8%
Net Profit YoY
2.9%
EPS (diluted)
$1.38
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NWN
NWN
RPRX
RPRX
Q4 25
$394.2M
$622.0M
Q3 25
$164.7M
$609.3M
Q2 25
$236.2M
$578.7M
Q1 25
$494.3M
$568.2M
Q4 24
$370.9M
$593.6M
Q3 24
$136.9M
$564.7M
Q2 24
$211.7M
$537.3M
Q1 24
$433.5M
$568.0M
Net Profit
NWN
NWN
RPRX
RPRX
Q4 25
$214.2M
Q3 25
$-29.9M
$288.2M
Q2 25
$-2.5M
$30.2M
Q1 25
$87.9M
$238.3M
Q4 24
$208.2M
Q3 24
$-27.2M
$544.0M
Q2 24
$-2.8M
$102.0M
Q1 24
$63.8M
$4.8M
Operating Margin
NWN
NWN
RPRX
RPRX
Q4 25
28.4%
62.4%
Q3 25
-7.5%
70.1%
Q2 25
11.5%
36.3%
Q1 25
31.2%
94.0%
Q4 24
22.9%
60.9%
Q3 24
-14.1%
Q2 24
7.4%
50.2%
Q1 24
25.3%
-13.0%
Net Margin
NWN
NWN
RPRX
RPRX
Q4 25
34.4%
Q3 25
-18.1%
47.3%
Q2 25
-1.1%
5.2%
Q1 25
17.8%
41.9%
Q4 24
35.1%
Q3 24
-19.8%
96.3%
Q2 24
-1.3%
19.0%
Q1 24
14.7%
0.8%
EPS (diluted)
NWN
NWN
RPRX
RPRX
Q4 25
$1.38
$0.49
Q3 25
$-0.73
$0.67
Q2 25
$-0.06
$0.07
Q1 25
$2.18
$0.55
Q4 24
$1.12
$0.46
Q3 24
$-0.71
$1.21
Q2 24
$-0.07
$0.23
Q1 24
$1.69
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NWN
NWN
RPRX
RPRX
Cash + ST InvestmentsLiquidity on hand
$36.7M
$618.7M
Total DebtLower is stronger
$2.4B
$9.0B
Stockholders' EquityBook value
$1.5B
$9.7B
Total Assets
$6.2B
$19.6B
Debt / EquityLower = less leverage
1.65×
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NWN
NWN
RPRX
RPRX
Q4 25
$36.7M
$618.7M
Q3 25
$32.2M
$938.9M
Q2 25
$102.6M
$631.9M
Q1 25
$100.0M
$1.1B
Q4 24
$38.5M
$929.0M
Q3 24
$35.0M
$950.1M
Q2 24
$65.2M
$1.8B
Q1 24
$72.4M
$843.0M
Total Debt
NWN
NWN
RPRX
RPRX
Q4 25
$2.4B
$9.0B
Q3 25
$2.2B
$8.9B
Q2 25
$2.2B
$8.0B
Q1 25
$2.2B
$7.6B
Q4 24
$1.7B
$7.6B
Q3 24
$1.6B
$7.6B
Q2 24
$1.6B
$7.6B
Q1 24
$1.6B
$6.1B
Stockholders' Equity
NWN
NWN
RPRX
RPRX
Q4 25
$1.5B
$9.7B
Q3 25
$1.4B
$9.6B
Q2 25
$1.5B
$9.5B
Q1 25
$1.5B
$9.8B
Q4 24
$1.4B
$10.3B
Q3 24
$1.4B
$10.3B
Q2 24
$1.3B
$9.8B
Q1 24
$1.3B
$9.9B
Total Assets
NWN
NWN
RPRX
RPRX
Q4 25
$6.2B
$19.6B
Q3 25
$5.9B
$19.3B
Q2 25
$5.8B
$18.3B
Q1 25
$5.7B
$17.6B
Q4 24
$5.2B
$18.2B
Q3 24
$4.9B
$18.0B
Q2 24
$4.8B
$17.7B
Q1 24
$4.8B
$16.1B
Debt / Equity
NWN
NWN
RPRX
RPRX
Q4 25
1.65×
0.92×
Q3 25
1.56×
0.93×
Q2 25
1.53×
0.84×
Q1 25
1.53×
0.78×
Q4 24
1.23×
0.74×
Q3 24
1.16×
0.74×
Q2 24
1.17×
0.78×
Q1 24
1.17×
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NWN
NWN
RPRX
RPRX
Operating Cash FlowLast quarter
$3.3M
$827.1M
Free Cash FlowOCF − Capex
$-131.0M
FCF MarginFCF / Revenue
-33.2%
Capex IntensityCapex / Revenue
34.1%
Cash ConversionOCF / Net Profit
3.86×
TTM Free Cash FlowTrailing 4 quarters
$-197.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NWN
NWN
RPRX
RPRX
Q4 25
$3.3M
$827.1M
Q3 25
$-15.9M
$702.6M
Q2 25
$102.2M
$364.0M
Q1 25
$179.6M
$596.1M
Q4 24
$-19.4M
$742.5M
Q3 24
$-26.4M
$703.6M
Q2 24
$121.0M
$658.2M
Q1 24
$125.0M
$664.6M
Free Cash Flow
NWN
NWN
RPRX
RPRX
Q4 25
$-131.0M
Q3 25
$-125.9M
Q2 25
$-18.3M
Q1 25
$77.4M
Q4 24
$-119.6M
Q3 24
$-121.7M
Q2 24
$4.3M
Q1 24
$42.8M
FCF Margin
NWN
NWN
RPRX
RPRX
Q4 25
-33.2%
Q3 25
-76.4%
Q2 25
-7.8%
Q1 25
15.7%
Q4 24
-32.2%
Q3 24
-88.9%
Q2 24
2.0%
Q1 24
9.9%
Capex Intensity
NWN
NWN
RPRX
RPRX
Q4 25
34.1%
Q3 25
66.8%
Q2 25
51.0%
Q1 25
20.7%
Q4 24
27.0%
Q3 24
69.6%
Q2 24
55.1%
Q1 24
19.0%
Cash Conversion
NWN
NWN
RPRX
RPRX
Q4 25
3.86×
Q3 25
2.44×
Q2 25
12.06×
Q1 25
2.04×
2.50×
Q4 24
3.57×
Q3 24
1.29×
Q2 24
6.45×
Q1 24
1.96×
139.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NWN
NWN

NWN Gas Utility$341.4M87%
Alternativerevenue$27.2M7%
Si Energy Gas Utility$20.0M5%
NW Natural Other$6.9M2%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

Related Comparisons